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Background: Interindividual differences in response to weight loss and maintenance thereafter are ascribed to
genetic predisposition and behavioral changes.
Objective: To examinewhether body weight and short and long-term body weight loss were affected by candidate
single nucleotide polymorphisms (SNPs) and changes in eating behavior or by an interaction between these genetic
and behavioral factors.
Methods: 150 healthy subjects (39 males, 111 females) aged 20–50 y with a BMI of 27–38 kg/m2 followed a very
low energy diet for 8-weeks, followed by a 3-month weight maintenance period. SNPs were selected from six
candidate genes: ADRB2, FTO, MC4R, PPARG, PPARD, and PPARGC1A. Changes in eating behavior were determined
with the Three Factor Eating Questionnaire.
Results: A high genetic predisposition score was associated with a high body weight at baseline and more short-
term weight loss. From the six selected obesity-related SNPs, FTO was associated with increased body weight at
baseline, and the effect allele of PPARGC1A was positively associated with short-term weight loss, when assessed
for each SNP separately. Long-termweight loss was associated with a larger increase in dietary restraint and larger
decrease in disinhibition.
Conclusion: During long-term weight loss, genetic effects are dominated by changes in eating behavior.© 2014 Elsevier Inc. All rights reserved.1. Introduction
Obesity results from a chronic imbalance between energy intake and
expenditure [1]. The increasing prevalence of obesity coincides with
changes in dietary habits due to high availability of energy-dense
foods, suggesting a causal link [2]. However, some individuals seem
resistant to becoming overweight or obese. Inter-individual variation
in the susceptibility to develop obesity can be partly explained by
genetics. Family and twin studies have shown that the genetic con-
tribution can be 40–70% [3,4]. Genome-wide association studies
(GWAS), already identified 52 genetic loci to be unequivocally asso-
ciated with obesity related-traits [5]. However, the effects of the loci31 43 3670976.
.M. Verhoef).on obesity-susceptibility are small and explain only a small fraction
of the total variation with a poor predictive ability [5–7]. Studying
the GWAS-identified loci in longitudinal cohort studies can contribute
to elucidating new physiological pathways that underlie obesity-
susceptibility.
Most association studies focus on single nucleotide polymorphisms
(SNPs) in relation to body weight, instead of changes in body weight.
Successfully maintaining weight loss, defined as “keeping off an inten-
tional loss of at least 10% body weight for at least one year” is only
achieved in around 20% of the cases [8,9]. Individual differences in
weight loss and regainmay in part be caused by a genetic predisposition
to resist weight loss or promotingweight gain [10]. Twin studies on the
response to long-term negative energy balance have demonstrated
a much larger variability between pairs than within pairs [11,12],
suggesting that there is also a genetic contribution in the resistance
for body weight loss and maintenance.
Table 1
Subject characteristics (mean ± SD) on baseline (t0), after weight loss (t2) and after 3-
month (t5).
t0 t2 t5 P-valuea
Body weight (kg) 92.6 ± 12.3 83.2 ± 10.9b 84.7 ± 11.7b b0.001
BMI (kg/m2) 32.0 ± 3.1 28.7 ± 3.0b 29.2 ± 3.2b b0.001
Fat mass (kg) 38.6 ± 7.8 31.2 ± 7.8b 30.9 ± 8.6b b0.001
Percentage fat mass (%) 41.6 ± 6.6 37.4 ± 7.4b 33.5 ± 8.5b b0.001
Dietary restraint 7.5 ± 3.8 12.4 ± 4.2b 12.0 ± 4.2b b0.001
Disinhibition 6.5 ± 2.7 4.9 ± 2.6b 5.3 ± 2.8b b0.001
Hunger 5.1 ± 3.0 3.7 ± 3.0b 3.4 ± 2.9b b0.001
BMI: body mass index.
a Difference over time (repeated measures ANOVA).
b Significantly different from baseline, P b 0.01.
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genetic variants, which had shown associations with obesity-related
traits: rs9939609 of fat mass and obesity associated (FTO) gene;
rs17782313 of melanocortin 4 receptor (MC4R) gene; rs1042713 of
β2-adrenergic receptor (ADRB2) gene; rs1801282 of peroxisome
proliferator-activated receptorγ2 (PPARγ2) gene; rs8192678 of peroxi-
some proliferator-activated receptorγ coactivator-1α (PPARGC1α)
gene; and rs2076168 of peroxisome proliferator-activated receptorδ
(PPARδ) gene. The aim of the study was to examine whether body
weight changes during an 8-week weight loss period and subsequent
follow-up of 3-months were affected by the six selected SNPs and by
changes in eating behavior, or by an interaction between these genetic
and behavioral factors.
2. Material and methods
2.1. Subjects
150 healthy subjects (39 males, 111 females) aged 20–50 y with a
BMI of 27–38 kg/m2 participated in the study, which started in February
2010. The weight loss diet consisted of 8 weeks of very low energy diet
providing 2.1 MJ/day (Modifast; Nutrition et Santé Benelux, Breda, The
Netherlands). This dietwas a protein-enriched formula diet that provided
50 g carbohydrates, 52 g protein, 7 g fat and a micronutrient content,
which meets the Dutch recommended daily allowance. Vegetables
were allowed in addition to the diet. Theweight loss periodwas followed
by a weight maintenance period of 3 months, in which subjects were
instructed tomaintain their newly achieved bodyweight. Measurements
were done at rest and following an overnight fast at three time points;
before weight loss, after weight loss and after 3 months follow-up. The
study was conducted according to the guidelines laid down in the Decla-
ration of Helsinki and all procedures involving human subjects were
approved by the Central Committee on Human Research and by the
Medical Ethical Committee of Maastricht University. Written informed
consent was obtained from all subjects. The study was registered in
ClinicalTrials.gov (registration number: NCT01015508).
2.2. Anthropometry
Heightwasmeasured at screening to the nearest 0.1 cmwith the use
of a wall-mounted stadiometer (model 220; Seca, Hamburg, Germany).
Body weight was measured with subjects in underwear after an over-
night fast using a calibrated scale of the BodPod®. Body mass index
(BMI)was calculated by dividing bodyweight by height squared (kg/m2).
Body composition was calculated from body volume (BodPod®, Life
measurement, Concord, CA, USA) [13] and total body water (TBW) [14]
as assessed with the deuterium dilution technique, using Siri's three-
compartment model [15]. The dilution of the deuterium isotope
(2H2O) is a measure for total body water. Subjects wore tightly fitting
bathing suits and a swim cap during the volume-measurements in the
BodPod®, and had not engaged in exercise at least 1 h prior to the test.
2.3. Questionnaires
To determine whether attitude toward food intake changed during
weight loss and maintenance, a validated Dutch translation of the
three-factor eating questionnaire (TFEQ) was used [16]. Changes in
dietary restraint and disinhibition scores were used as indicators for
changes in eating behavior and different disinhibition and restraint
outcomes have been associated with distinct weight and behavior
outcomes [17].
2.4. DNA isolation and genotyping
Blood was collected in an EDTA tube during screening and the buffy
coat was stored at −80 °C. Genomic DNA was isolated from the buffycoat using the QIAamp mini blood kit (Qiagen, Amsterdam, The
Netherlands). Six SNPs were selected based on GWAS and intervention
studies, which associated them with obesity (Table 1). Genotypes were
coded0, 1 or 2 according to thenumber of risk alleles for each SNP. From
these codes a genetic predisposition score (GPS) was constructed for
each individual by summing the risk alleles across the six SNPs, as pre-
viously done by other authors [5,18,19].
Genotyping of five SNPs was performed using commercially available
TaqMan SNP genotyping assays from Applied Biosystems (Foster City,
California, USA). The procedure was performed according to the
manufacturer's protocol and measured on an Applied Biosystems 7900
HT Fast Real-Time PCR system. Allelic calls were determined semi-
automatically using the allelic discrimination software of Applied
Biosystems. The Pro12Ala polymorphism of the PPARγ2 genewas charac-
terized using the polymerase chain reaction–restriction fragment length
polymorphism (PCR–RFLP) assay. The primers used were 5′-GCCAATTC
AAGCCCAGTC-3′ and 5′-GATATGTTTGCAGACAGTGTATCAGTGAAGGAAT
CGCTTTCCG-3′. The cycling conditions were 95 °C for 5 min, 30 cycles
of 95 °C/30 s, 56 °C/45 s, 68 °C/45 s and followed by 68 °C for 7 min.
The restriction enzyme BstU-I was used, which generated the following
fragments: 270 bp (Pro12Pro); 270, 227, 43 bp (Pro12Ala) and 227,
43 bp (Ala12Ala).
2.5. Statistical analysis
Data are presented as mean and their standard deviations, unless
otherwise indicated. A Chi-square test was used to check whether the
allele frequencies were in HardyWeinberg equilibrium. ANOVA repeated
measureswas carried out to determine changes over time.Mean baseline
values and changes in weight during weight loss and follow-up periods
were compared between groups with ANOVA. Corrections for multiple
testing were performed by using Bonferroni correction. Each SNP was
tested individually, with age, sex and baseline value for that particular
dependent variable as covariates. Linear regressions were used to test
for associations. Significance was defined as P b 0.05. All of the statistical
analyses were executedwith SPSS version 16.0 forMacintosh OS X (SPSS
Inc., Chicago, IL).
3. Results
Body weight, BMI, fat mass, percentage fat mass, and waist and hip
circumference decreased significantly during weight loss and remained
significantly lower after 3-month follow-up compared to baseline
(Table 1). Dietary restraint increased and disinhibition and hunger de-
creased significantly during weight loss and remained significantly
below baseline values during follow-up.
3.1. Genetic predisposition
All SNPswere inHardyWeinberg equilibrium (Table 2). To determine
the genetic contribution of the selected SNPs, differences in body weight
at baseline and body weight changes during short and long-termweight
Table 2
Genotypic and allelic distributions per single nucleotide polymorphism.
Gene SNP G F (N) F (%) Allelea F (%) HWE
FTO rs9936909 AA 25 16.9 A 38.9 0.65
AT 65 43.9 T 61.1
TT 58 39.2
MC4R rs17782313 CC 15 10.1 C 24.1 0.19
CT 46 31.1 T 75.9
TT 87 58.8
ADRB2 rs1042713 GG 56 37.8 G 62.3 0.92
GA 71 48.0 A 37.7
AA 21 14.2
PPARD rs2076168 GG 16 10.9 G 28.1 0.33
GT 52 35.4 T 71.9
TT 79 53.7
PPARGC1A rs8192678 AA 20 13.6 A 37.2 0.95
AG 70 47.6 G 62.8
GG 57 38.8
PPARG2 rs1801282 Ala12Ala 1 0.7 Ala 10.7 0.83
(Pro12Ala) Pro12Ala 30 20.1 Pro 89.3
Pro12Pro 118 79.2
G, genotype; F, frequency, both absolute (N) and relative (%).
P-values obtained from the χ2-test of Hardy Weinberg equilibrium (HWE).
a Effect allele in bold.
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more, a GPS was calculated by summing the risk alleles across the six
SNPs. Multiple regression showed a positive association between GPS
and body weight at baseline (Table 4), with a higher GPS associated
with a higher body weight at baseline. There was no unifying effect on
body weight as the GPS might have suggested when the effect of the
SNPs separatelywas assessed (Table 3). Therewas a significant difference
in body weight at baseline between FTO genotypes, with a higher body
weight with the effect allele. More weight loss during energy restriction
was associated with a high GPS (Table 4), thereby taking into account
baseline body weight. Multiple regression with the percentage weight
loss showed the same results (results not shown). Subjectswith the effect
allele for PPARGC1A had more short-term weight loss. During long-term
weight loss there were no significant associations with GPS. Long-term
weight loss was significantly different between MC4R genotypes, with
lessweight loss after 3-month follow-up compared to baseline in subjects
with the effect allele.Table 3
Baseline and changes in body weight (kg) during short- and long-term weight loss.
Gene Effect allele Genotype Baseline weight (t0)a
Mean ± SE P-valu
FTO A AA 96.0 ± 2.4 0.017
AT 93.9 ± 1.3
TT 90.5 ± 1.3
MC4R C CC 96.6 ± 3.1 0.353
CT 91.3 ± 1.6
TT 92.6 ± 1.2
ADRB2 G GG 93.5 ± 1.6 0.208
GA 93.1 ± 1.3
AA 89.4 ± 2.2
PPARD G GG 91.8 ± 2.8 0.530
GT 91.4 ± 1.6
TT 93.7 ± 1.2
PPARGC1A A AA 92.9 ± 2.6 0.112
AG 94.2 ± 1.3
GG 91.4 ± 1.4
PPARG2 Ala Pro12Ala 93.8 ± 2.1 0.725
Pro12Pro 92.3 ± 1.0
a Adjusted for age and sex.
b Adjusted for age, sex and baseline weight.
c Adjusted for age, sex, baseline weight and weight loss (t2 − 0).Additionally, results for differences in fat mass and percentage fat
mass between genotypes were comparable to those for body weight as
reported above (data not shown). For dietary restraint, disinhibition and
hunger scores, there were no significant differences between genotypes.
3.2. Eating behavior
Changes in dietary restraintwere inversely correlatedwith changes in
disinhibition during both short and long-term weight loss (respectively
R2 = 0.044 P = 0.011 and R2 = 0.082 P b 0.001). Body weight at base-
line was significantly correlated with dietary restraint and disinhibition,
but did not reach significance after adjusting for age and gender
(Table 5). In a multiple regression together with SNPs that showed a sig-
nificant effect, body weight at baseline was associated with gender and
FTO. Short-termweight loss was associatedwith bodyweight at baseline,
gender and PPARGC1A. Long-term weight loss was associated with the
amount of weight lost during energy restriction, gender and the change
in dietary restraint and disinhibition after 3-month follow-up. No signif-
icant interaction effects between the genetic and behavioral factors
were found.
4. Discussion
A high GPS was associated with a high body weight at baseline and
more short-term weight loss. From the six selected obesity-related
SNPs in this study, FTO was associated with increased body weight at
baseline. The effect allele of PPARGC1Awas associated with short-term
weight loss when assessed for each SNP separately. Long-term weight
loss was associated with a larger increase in dietary restraint and larger
decrease in disinhibition.
Based on literature six SNPswere selected as being related to obesity
associated-traits, and thus suggested to be candidates for associations
with body weight changes. The correlations with GPS indicate that the
SNPs have a negative effect on body weight, but a positive effect on
short-term weight loss, with subjects with the most effect alleles losing
more weight during energy restriction. However, when assessed for
each SNP separately merely FTO and body weight and PPARGC1A and
short-term weight loss were significantly associated. For FTO rs9936909,
body weight at baseline was higher in A-allele carriers, while there
were no differences in weight loss consistent with previous studiesShort-term weight loss
(t2 − 0)b
Long-termweight loss (t5 − 0)c
e Change ± SE P-value Change ± SE P-value
−9.9 ± 0.8 0.333 −8.8 ± 0.6 0.411
−9.7 ± 0.4 −8.0 ± 0.4
−8.9 ± 0.4 −7.8 ± 0.4
−8.2 ± 1.0 0.422 −7.5 ± 0.9 0.049
−9.6 ± 0.5 −7.2 ± 0.4
−9.5 ± 0.4 −8.6 ± 0.3
−9.9 ± 0.5 0.346 −7.3 ± 0.4 0.190
−9.0 ± 0.4 −8.1 ± 0.4
−8.8 ± 0.7 −8.6 ± 0.6
−9.9 ± 0.9 0.525 −8.4 ± 0.8 0.385
−9.5 ± 0.5 −7.4 ± 0.4
−9.0 ± 0.4 −8.1 ± 0.3
−10.7 ± 0.8 0.023 −9.1 ± 0.7 0.290
−9.8 ± 0.4 −7.9 ± 0.4
−8.5 ± 0.4 −7.8 ± 0.7
−10.1 ± 0.7 0.189 −7.6 ± 0.6 0.525
−9.2 ± 0.3 −8.0 ± 0.3
Table 4
Multiple regression between body weight and body weight changes with GPS.
Response Parameter B ± SE β P-value
Baseline
weight (t0)
GPS 1.14 ± 0.57 0.15 0.049
Gender −15.38 ± 2.28 −0.52 0.000
Age −0.03 ± 0.11 −0.02 0.821
Short-term weight
loss (t2 − 0)
GPS −0.52 ± 0.18 −0.21 0.004
Gender 2.86 ± 0.82 0.30 0.000
Baseline weight (t0) −0.11 ± 0.03 −0.30 0.001
Age 0.04 ± 0.04 0.07 0.317
Response; dependent variable.
Parameter; independent variable.
B; unstandardized regression coefficient.
β; standardized regression coefficient.
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PPARGC1A rs8192678 lost more weight, but this effect was lost during
long-term weight loss. There were also no differences in baseline body
weight between PPARGC1A genotypes. These results were in contrast to
previous studies, which showed associations with body weight and not
with weight changes [23,24]. Long-term weight loss was significantly
lower in subjects with the C-allele of MC4R rs17782313, while others
have shown that this SNP was associated with body weight and not
weight changes [25,26]. In contrast to what we expected from the litera-
ture, therewere in addition to PPARGC1A andMC4R also no significant dif-
ferences in body weight for the ADRB2 rs1042713 and PPARD rs2076168
[27,28]. Although not many studies determined the relation between
SNPs and weight changes, most associations were found with PPARG2
rs1801282 [29–33], but our results could not confirm this. Many explana-
tions for the inconsistent results in the literature have already been pro-
posed, like low sample size, limitations of study populations and
different study designs. However, a probably more important factor is
the largely unknown gene–environment interactions that can mask the
effect of a genetic variant, as described by Andreasen et al. [34]. Especially
during a period of conscious weight loss, behavioral changes might dom-
inate genetic effects. Furthermore, comparing studies using GPS is diffi-
cult, because a calculated GPS is not a constant variable and is different
in each study depending on the different SNPs selected.
Dietary restraint and disinhibition have emerged from the literature
as important indicators for eating behavior and different disinhibition
and restraint outcomes have been associated with distinct weight and
behavior outcomes [17]. Here, changes in dietary restraint and disinhibi-
tion were inversely correlated with each other, consistent with previousTable 5
Multiple regression between body weight at baseline and body weight changes with SNPs, die
Response Parameter









Dietary restraint (t2 − 0)
Disinhibition (t2 − 0)
Long-term weight loss (t5 − 0) Age
Gender
MC4R
Weight loss (t2 − 0)
Dietary restraint (t5 − 0)
Disinhibition (t5 − 0)
Response; dependent variable.
Parameter; independent variable.
B; unstandardized regression coefficient.
β; standardized regression coefficient.studies [35–38]. Both changes in dietary restraint and disinhibitionwere
correlated with long-term weight loss, emphasizing the importance of
both factors during periods of weight maintenance. These results con-
firm findings of previous studies that already have shown that the in-
crease in dietary restraint was associated with more success in weight
maintenance [37,39,40]. There was no effect of the SNPs on dietary re-
straint and disinhibition or changes in these factors, so changes in eating
behavior independently predict success in long-term weight loss.
From these results we cannot exclude whether there were gene–
environment interactions masking effects of a genetic variant. In
turn, dietary restraint and disinhibition do not fully cover behavioral
factors, thoughwidely used to characterize eating behavior. In addition,
six SNPs asmeasured in 150 subjects are low compared to other genetic
studies. However, this is a consequence of the design of our study, since
accurate assessment of short and long-term weight loss was a limiting
factor. Since these measurements are part of a larger intervention
study, the selection of the SNPs comprised those previously associated
with obesity-related traits in general and not specifically personality
traits.
In conclusion, long-termweight loss ismainly determined by changes
in eating behavior.
Acknowledgments
K.R. Westerterp and S.P.M. Verhoef designed the study. S.P.M.
Verhoef, S.G.J.A. Camps and F.G. Bouwman collected the data. S.P.M.
Verhoef analyzed the data and wrote the manuscript. K.R. Westerterp
and E.C.M. Mariman contributed to the interpretation of the data and
reviewed the manuscript. The study was executed under supervision
of K.R. Westerterp. All authors read and approved the final manuscript.
None of the authors had any conflict of interest.
References
[1] Tremblay A, Perusse L, Bouchard C. Energy balance and body-weight stability:
impact of gene–environment interactions. Br J Nutr 2004;92(Suppl. 1):S63–6.
[2] Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we
go from here? Science 2003;299:853–5.
[3] Loos RJ, Bouchard C. Obesity—is it a genetic disorder? J Intern Med 2003;254:401–25.
[4] Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body
weight and human adiposity. Behav Genet 1997;27:325–51.
[5] Li S, Zhao JH, Luan J, Luben RN, Rodwell SA, Khaw KT, et al. Cumulative effects and
predictive value of common obesity-susceptibility variants identified by genome-
wide association studies. Am J Clin Nutr 2010;91:184–90.
[6] Loos RJ. Genetic determinants of common obesity and their value in prediction. Best
Pract Res 2012;26:211–26.tary restraint and disinhibition.
B ± SE β P-value
0.01 ± 0.10 0.00 0.959
−13.69 ± 2.17 −0.49 0.000
3.26 ± 1.29 0.18 0.012
0.11 ± 0.24 0.03 0.654
−0.48 ± 0.33 −0.11 0.156
0.03 ± 0.03 0.06 0.410
2.70 ± 0.78 0.29 0.001
−1.15 ± 0.42 −0.20 0.008
−0.11 ± 0.03 −0.33 0.000
−0.06 ± 0.06 −0.07 0.346
0.01 ± 0.12 0.01 0.912
−0.05 ± 0.03 −0.08 0.077
−1.94 ± 0.61 −0.17 0.002
0.57 ± 0.37 0.07 0.123
1.02 ± 0.07 0.82 0.000
−0.23 ± 0.07 −0.18 0.001
0.25 ± 0.11 0.12 0.024
251S.P.M. Verhoef et al. / Physiology & Behavior 128 (2014) 247–251[7] Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Asso-
ciation analyses of 249,796 individuals reveal 18 new loci associatedwith bodymass
index. Nat Genet 2010;42:937–48.
[8] Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr 2001;21:323–41.
[9] Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr
2005;82:222S–5S.
[10] Mariman E. Human biology of weight maintenance after weight loss. J Nutrigenet
Nutrigenomics 2012;5:13–38.
[11] Bouchard C, Tremblay A, Despres JP, Theriault G, Nadeau A, Lupien PJ, et al. The re-
sponse to exercise with constant energy intake in identical twins. Obes Res
1994;2:400–10.
[12] Hainer V, Stunkard AJ, Kunesova M, Parizkova J, Stich V, Allison DB. Intrapair resem-
blance in very low calorie diet-induced weight loss in female obese identical twins.
Int J Obes Relat Metab Disord 2000;24:1051–7.
[13] Dempster P, Aitkens S. A new air displacement method for the determination of
human body composition. Med Sci Sports Exerc 1995;27:1692–7.
[14] Westerterp KR, Wouters L, van Marken Lichtenbelt WD. The Maastricht protocol for
the measurement of body composition and energy expenditure with labeled water.
Obes Res 1995;3(Suppl. 1):49–57.
[15] Siri W. Body composition from fluid spaces and density: analysis of methods. In:
Brozek J, Henschel A, editors. Techniques formeasuring body composition.Washington
DC: National Academy of Science; 1961. p. 223–44.
[16] Stunkard A, Messick S. The three-factor eating questionnaire to measure dietary
restraint, disinhibition and hunger. J Psychosom Res 1985;29:71–83.
[17] Bryant EJ, King NA, Blundell JE. Disinhibition: its effects on appetite and weight
regulation. Obes Rev 2008;9:409–19.
[18] den HoedM, Ekelund U, Brage S, Grontved A, Zhao JH, Sharp SJ, et al. Genetic suscep-
tibility to obesity and related traits in childhood and adolescence: influence of loci
identified by genome-wide association studies. Diabetes 2010;59:2980–8.
[19] Peterson RE, Maes HH, Holmans P, Sanders AR, Levinson DF, Shi J, et al. Genetic risk
sum score comprised of common polygenic variation is associated with body mass
index. Hum Genet 2011;129:221–30.
[20] Franks PW, Jablonski KA, Delahanty LM, McAteer JB, Kahn SE, Knowler WC,
et al. Assessing gene-treatment interactions at the FTO and INSIG2 loci on
obesity-related traits in the Diabetes Prevention Program. Diabetologia
2008;51:2214–23.
[21] Grau K, Hansen T, Holst C, Astrup A, Saris WH, Arner P, et al. Macronutrient-specific
effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet
among obese Europeans. Int J Obes 2009;33:1227–34 [(2005)].
[22] Lappalainen TJ, Tolppanen AM, Kolehmainen M, Schwab U, Lindstrom J, Tuomilehto
J, et al. The common variant in the FTO gene did not modify the effect of lifestyle
changes on body weight: the Finnish Diabetes Prevention Study. Obesity (Silver
Spring) 2009;17:832–6 [Md].
[23] Goyenechea E, Crujeiras AB, Abete I, Parra D, Martinez JA. Enhanced short-term im-
provement of insulin response to a low-caloric diet in obese carriers the Gly482Ser
variant of the PGC-1alpha gene. Diabetes Res Clin Pract 2008;82:190–6.
[24] Mirzaei K, Hossein-Nezhad A, Emamgholipour S, Ansar H, Khosrofar M, Tootee A,
et al. An exonic peroxisome proliferator-activated receptor-gamma coactivator-1
alpha variation may mediate the resting energy expenditure through a potential
regulatory role on important gene expression in this pathway. J Nutrigenet
Nutrigenomics 2012;5:59–71.[25] Haupt A, Thamer C, Heni M, Tschritter O, Machann J, Schick F, et al. Impact of varia-
tion near MC4R on whole-body fat distribution, liver fat, and weight loss. Obesity
(Silver Spring) 2009;17:1942–5 [Md].
[26] Kring SI, Holst C, Toubro S, Astrup A, Hansen T, Pedersen O, et al. Common variants
near MC4R in relation to body fat, body fat distribution, metabolic traits and energy
expenditure. Int J Obes 2010;34:182–9 [(2005)].
[27] Masuo K, Katsuya T, Kawaguchi H, Fu Y, Rakugi H, Ogihara T, et al. Rebound
weight gain as associated with high plasma norepinephrine levels that are
mediated through polymorphisms in the [beta]2-adrenoceptor. Am J Hypertens
2005;18:1508–16.
[28] Ruiz JR, Larrarte E, Margareto J, Ares R, Labayen I. Role of beta(2)-adrenergic receptor
polymorphisms on body weight and body composition response to energy restriction
in obese women: preliminary results. Obesity (Silver Spring) 2011;19:212–5 [Md].
[29] Goyenechea E, Dolores Parra M, Alfredo Martinez J. Weight regain after slim-
ming induced by an energy-restricted diet depends on interleukin-6 and
peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br
J Nutr 2006;96:965–72.
[30] Lindi VI, Uusitupa MI, Lindstrom J, Louheranta A, Eriksson JG, Valle TT, et al. Associ-
ation of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year inci-
dence of type 2 diabetes and body weight change in the Finnish Diabetes
Prevention Study. Diabetes 2002;51:2581–6.
[31] Nicklas BJ, van Rossum EFC, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Ge-
netic variation in the peroxisome proliferator‚ activated receptor-γ2 gene (Pro12Ala)
affects metabolic responses to weight loss and subsequent weight regain. Diabetes
2001;50:2172–6.
[32] Rosmond R, Chagnon M, Bouchard C. The Pro12Ala PPARgamma2 gene missense
mutation is associated with obesity and insulin resistance in Swedish middle-aged
men. Diabetes Metab Res Rev 2003;19:159–63.
[33] Vogels N, Mariman ECM, Bouwman FG, Kester ADM, Diepvens K, Westerterp-
Plantenga MS. Relation of weight maintenance and dietary restraint to peroxisome
proliferator-activated receptor {gamma}2, glucocorticoid receptor, and ciliary neu-
rotrophic factor polymorphisms. Am J Clin Nutr 2005;82:740–6.
[34] Andreasen CH, Andersen G. Gene–environment interactions and obesity—further as-
pects of genomewide association studies. , 25Nutrition (Burbank, Los Angeles Coun-
ty, Calif); 2009 998–1003.
[35] Dykes J, Brunner EJ, Martikainen PT, Wardle J. Socioeconomic gradient in body size
and obesity among women: the role of dietary restraint, disinhibition and hunger
in the Whitehall II study. Int J Obes Relat Metab Disord 2004;28:262–8.
[36] Hays NP, Bathalon GP, McCrory MA, Roubenoff R, Lipman R, Roberts SB. Eating be-
havior correlates of adult weight gain and obesity in healthy women aged 55–65
y. Am J Clin Nutr 2002;75:476–83.
[37] Vogels N, Westerterp-Plantenga MS. Successful long-termweight maintenance: a 2-
year follow-up. Obesity (Silver Spring) 2007;15:1258–66 [Md].
[38] Williamson DA, Lawson OJ, Brooks ER, Wozniak PJ, Ryan DH, Bray GA, et al. Associ-
ation of bodymass with dietary restraint and disinhibition. Appetite 1995;25:31–41.
[39] LejeuneMP, Van Aggel-Leijssen DP, Van BaakMA, Westerterp-Plantenga MS. Effects
of dietary restraint vs exercise during weight maintenance in obese men. Eur J Clin
Nutr 2003;57:1338–44.
[40] Westerterp-Plantenga MS, Kempen KP, Saris WH. Determinants of weight mainte-
nance in women after diet-induced weight reduction. Int J Obes Relat Metab Disord
1998;22:1–6.
